# TARGET Study Demonstrates Sustained Performance and Favorable Safety Profile of the Cardiovalve TR System in High-Risk Patients with Severe Tricuspid Regurgitation

- Source: PR Newswire M&A
- Published: 2026-11-22T15:30:00+00:00
- Category: Business
- Original: https://www.prnewswire.com/news-releases/target-study-demonstrates-sustained-performance-and-favorable-safety-profile-of-the-cardiovalve-tr-system-in-high-risk-patients-with-severe-tricuspid-regurgitation-302947606.html
- Canonical: https://groundlevelnews.com/story/target-study-demonstrates-sustained-performance-and-favorable-safety-p-9eaf50/

Late-breaking 6-month full cohort data presented at PCR London Valves 2026 shows durable tricuspid regurgitation reduction up to 3 years, positive right heart remodeling and quality-of-life improvements, as the company advances its CE Mark application. LONDON, Nov. 22, 2026 /PRNewswire/...

_Ground Level News shows a short summary only; the full article and all rights belong to PR Newswire M&A._
